ELISA in the evaluation of therapeutic response to albendazole in neurocysticercosis

Journal of Infection

Volumn 56, Issue 1, 2008, Pages 65-73

  Husain, Nuzhat ^a   Shukla, Nitin ^a   Kumar, Raj ^a   Husain, Mazhar ^a   Chaturvedi, Arun ^a   Agarwal, Girdhar G ^b   Gupta, Rakesh K ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Albendazole; CT scan; ELISA; IgG; IgM; Neurocysticercosis

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; STEROID;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL DECISION MAKING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTICERCUS (CESTODE LARVA); DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; NONHUMAN; PREDICTION; SENSITIVITY AND SPECIFICITY; TAENIA TAENIAEFORMIS;

ADOLESCENT; ADULT; AGED; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG MONITORING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; SENSITIVITY AND SPECIFICITY; TAENIA; TREATMENT OUTCOME;

EID: 37149042351     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.09.014     Document Type: Article

References (24)

1. Fleury A., Gomez T., Alvarez I., Meza D., Huerta M., Chavarria A., et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 22 (2003) 139-145
2. Gemmel M., Matyas Z., and Pawlowsky Z. Guidelines for surveillance, prevention and control of Taeniasis/cysticercosis (1983), WHO, Geneva
3. Del Brutto O.H., Raj Shekhar V., White Jr. A.C., Tsang V.C., Nash T.E., Takayanagui O.M., et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 (2001) 177-183
4. Diwan A.R., Cokervan-Vann M., Brown P., Subianto D.B., Yolken R., Desowitz R., et al. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium. Am J Trop Med Hyg 31 (1986) 364-369
5. Coker-Vann M., Brown P., and Gajdusek D.C. Serodiagnosis of human cysticercosis using a chromatofocused antigenic preparation of Taenia solium cysticerci in an enzyme-linked immunosorbent assay (ELISA). Trans R Soc Trop Med Hyg 78 (1984) 492-496
6. Malla N., Kaur M., Kaur U., Ganguly N.K., and Mahajan R.C. Evaluation of enzyme linked immunosorbent assay for the detection of anticysticercus antibodies in cerebrospinal fluid from patients with neurocysticercosis. J Hyg Epidemiol Microbiol Immunol 36 (1992) 181-190
7. Husain N., Jyotsna, M B., Husain M., Mishra M.K., and Gupta S. Evaluation of Cysticercus fasciolaris antigen for the immunodiagnosis of neurocysticercosis. Neurol India 49 (2001) 375-379
8. Garcia H.H., Gilman R.H., Catacora M., Verastegui M., Gonzalez A.E., and Tsang V.C. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. J Infect Dis 175 (1997) 486-489
9. Estanol B., Juarez H., Irigoyen Mdel C., Gonzalez-Barranco D., and Corona T. Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. J Neurol Neurosurg Psychiatry 52 (1989) 254-257
10. Cho S.Y., Kim S.K., and Kang S.Y. Serologic follow-up study in neurocysticercosis patients by ELISA after praziquantel treatment. Korean J Parasitol 23 (1986) 159-170
11. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2 (2002) 751-762
12. Shukla-Dave, Amita S., Roy R., Husain N., Paul L., Venkatesh S.K., et al. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions. Magn Reson Imaging 19 (2001) 103-110
13. Gupta R.K., Prakash M., Mishra A.M., Husain M., Prasad K.N., and Husain N. Role of diffusion weighted imaging in differentiation of intracranial tuberculoma and tuberculous abscess from cysticercus granulomas-a report of more than 100 lesions. Eur J Radiol 55 (2005) 384-392
14. Zhao S., and Xu K. Changes in computed tomogram in cerebral parenchymal cysticercosis treated with albendazole. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 17 (1999) 390-393
15. Garcia H.H., Parkhouse R.M., Gilman R.H., Montenegro T., Bernal T., Martinez S.M., et al. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg 92 (1998) 411-414
16. Ito A., Nakao M., Ito Y., Yuzawa I., Morishima H., Kawano N., et al. Neurocysticercosis case with a single cyst in the brain showing dramatic drop in specific antibody titers within 1 year after curative surgical resection. Parasitol Int 48 (1999) 95-99
17. Nguekam, Zoli A.P., Ongolo-Zogo P., Dorny P., Brandt J., and Geerts S. Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite 10 (2003) 65-68
18. Molinari J.L., Garcia-Mendoza E., de la Garza Y., Ramirez J.A., and Sotelo J. Discrimination between active and inactive neurocysticercosis by metacestode excretory/secretory antigens of Taenia solium in an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 66 (2002) 777-781
19. Morakote N., Nawacharoen W., Sukonthasun K., Thammasonthi W., and Khamboonruang C. Comparison of cysticercus extract, cyst fluid and Taenia saginata extract for use in ELISA for serodiagnosis of neurocysticercosis. Southeast Asian J Trop Med Public Health 23 (1992) 77-81
20. Larralde C., Sotelo J., Montoya R.M., Palencia G., Padilla A., Govezensky T., et al. Immunodiagnosis of human cysticercosis in cerebrospinal fluid. Antigens from murine Taenia crassiceps cysticerci effectively substitute those from porcine Taenia solium. Arch Pathol Lab Med 114 (1990) 926-928
21. Pardini A.X., Peralta R.H., Vaz A.J., Machado L.R., and Peralta J.M. Use of Taenia crassiceps cysticercus antigen preparations for detection of antibodies in cerebrospinal fluid samples from patients with neurocysticercosis (Taenia solium). Clin Diagn Lab Immunol 9 (2002) 190-193
22. Espindola N.M., Iha A.H., Fernandes I., Takayanagui O.M., Machado Ldos R., Livramento J.A., et al. Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography. J Clin Microbiol 43 (2005) 3178-3184
23. Salinas R, Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of the brain). Oxford: Cochrane database of systematic reviews (2) (update software 2000:CD000215).
24. Garcia H.H., Pretell E.J., Gilman R.H., Martinez S.M., Moulton L.H., Del Brutto O.H., et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350 (2004) 249-258